LU88579I2 - ATOVAQUONE et ses sels pharmaceutiquement acceptables (WELLVONE R) - Google Patents

ATOVAQUONE et ses sels pharmaceutiquement acceptables (WELLVONE R)

Info

Publication number
LU88579I2
LU88579I2 LU88579C LU88579C LU88579I2 LU 88579 I2 LU88579 I2 LU 88579I2 LU 88579 C LU88579 C LU 88579C LU 88579 C LU88579 C LU 88579C LU 88579 I2 LU88579 I2 LU 88579I2
Authority
LU
Luxembourg
Prior art keywords
wellvone
atovaquone
pharmaceutically acceptable
acceptable salts
alkyl
Prior art date
Application number
LU88579C
Other languages
English (en)
French (fr)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of LU88579I2 publication Critical patent/LU88579I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30—Unsaturated compounds
    • C07C62/34—Unsaturated compounds containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00—Preparation of quinones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/32—Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/08—Saturated compounds having a carboxyl group bound to a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/15—Saturated compounds containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16—Unsaturated compounds
    • C07C61/39—Unsaturated compounds containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16—Unsaturated compounds
    • C07C61/40—Unsaturated compounds containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/08—Saturated compounds containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/08—Saturated compounds containing ether groups, groups, groups, or groups
    • C07C62/10—Saturated compounds containing ether groups, groups, groups, or groups with a six-membered ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU88579C 1983-04-14 1984-04-14 ATOVAQUONE et ses sels pharmaceutiquement acceptables (WELLVONE R) LU88579I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838310141A GB8310141D0 (en) 1983-04-14 1983-04-14 Naphthoquinone derivatives

Publications (1)

Publication Number Publication Date
LU88579I2 true LU88579I2 (fr) 1995-03-01

Family

ID=10541105

Family Applications (1)

Application Number Title Priority Date Filing Date
LU88579C LU88579I2 (fr) 1983-04-14 1984-04-14 ATOVAQUONE et ses sels pharmaceutiquement acceptables (WELLVONE R)

Country Status (17)

Country Link
EP (1) EP0123238B1 (enExample)
JP (1) JPS59205341A (enExample)
AT (1) ATE27696T1 (enExample)
AU (1) AU574353B2 (enExample)
CY (1) CY1549A (enExample)
DE (2) DE19475021I2 (enExample)
DK (1) DK172273B1 (enExample)
GB (1) GB8310141D0 (enExample)
HK (1) HK56690A (enExample)
IL (1) IL71545A (enExample)
LU (1) LU88579I2 (enExample)
MX (1) MX9202993A (enExample)
MY (1) MY102117A (enExample)
NL (1) NL950002I2 (enExample)
PH (1) PH22018A (enExample)
SG (1) SG39390G (enExample)
ZA (1) ZA842797B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
US5175319A (en) * 1983-04-14 1992-12-29 Burroughs Wellcome Co. Naphthoquinone derivatives
EP0253501A3 (en) * 1986-07-16 1990-04-04 Imperial Chemical Industries Plc N-disubstituted cycloalkylmethyl amines useful as fungicides
DE3801743A1 (de) * 1987-07-03 1989-01-19 Bayer Ag Schaedlingsbekaempfungsmittel auf basis von substituierten 1,4-naphthochinonen und neue substituierte 1,4-naphthochinone
CA1329621C (en) * 1988-08-16 1994-05-17 Victoria Susan Latter Naphthoquinones in the treatment or prophylaxis of pneumocystis carinii infections
GB8819477D0 (en) * 1988-08-16 1988-09-21 Wellcome Found Medicaments
US5225184A (en) * 1988-08-16 1993-07-06 Burroughs Wellcome Co. Medicaments
US5206268A (en) * 1988-08-16 1993-04-27 Burroughs Wellcome Co. Medicaments
GB8921516D0 (en) * 1989-09-22 1989-11-08 Wellcome Found Medicaments
EP0567162A1 (en) * 1989-09-22 1993-10-27 The Wellcome Foundation Limited Medicaments for the treatment of toxoplasmosis
GB8923254D0 (en) * 1989-10-16 1989-12-06 Wellcome Found Medicaments
GB9126874D0 (en) * 1991-12-18 1992-02-19 Wellcome Found Medicaments
GB9207517D0 (en) * 1992-04-06 1992-05-20 Wellcome Found Heterocyclic compounds
GB9216859D0 (en) * 1992-08-07 1992-09-23 Wellcome Found Medicaments
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
US5856362A (en) * 1994-09-02 1999-01-05 Glaxo Wellcome Inc. Medicaments for the treatment of toxoplasmosis
WO2006008752A1 (en) * 2004-07-16 2006-01-26 Usv Limited Novel polymorphs of atovaquone and process of preparation thereof
WO2006011394A1 (ja) * 2004-07-30 2006-02-02 Japan Health Sciences Foundation 抗原虫剤
ITMI20070941A1 (it) * 2007-05-09 2008-11-10 Chimico Internazi0Nale S P A L Procedimento per la preparazione di naftochinoni trans2,3-disostituiti
CN101774901B (zh) * 2009-01-09 2012-10-03 武汉泰祥通生物技术有限公司 一种制备阿托伐醌的方法
ES2517366T3 (es) 2009-08-20 2014-11-03 Ipca Laboratories Limited Nuevo complejo para el tratamiento y/o profilaxis de infecciones parasitarias
GB2476644B (en) * 2009-12-23 2012-11-14 Haomamedica Ltd 1,4-Dihydro-1,4-dioxonaphtalene derivatives for the treatment of osteoporosis
US8598387B2 (en) 2010-12-15 2013-12-03 Glaxo Group Limited Process for the preparation of atovaquone
EP2845588A1 (en) * 2013-09-09 2015-03-11 Centre National de la Recherche Scientifique (C.N.R.S.) PIN1 inhibitors for use in the prevention and/or treatment of theileriosis, and related applications

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2553647A (en) * 1946-03-20 1951-05-22 Research Corp Naphthoquinone antimalarials
IL56013A (en) * 1977-11-22 1983-06-15 Wellcome Found 2-cycloalkyl-3-hydroxy-1,4-naphthoquinone derivatives,their preparation and therapeutic compositions containing them

Also Published As

Publication number Publication date
DK193584A (da) 1984-10-15
JPH0533212B2 (enExample) 1993-05-19
EP0123238A2 (en) 1984-10-31
HK56690A (en) 1990-08-03
EP0123238B1 (en) 1987-06-10
DK172273B1 (da) 1998-02-16
DE3464132D1 (de) 1987-07-16
GB8310141D0 (en) 1983-05-18
NL950002I1 (nl) 1995-03-01
EP0123238A3 (en) 1985-10-30
IL71545A (en) 1987-12-20
PH22018A (en) 1988-05-13
MY102117A (en) 1992-03-31
DK193584D0 (da) 1984-04-13
MX9202993A (es) 1992-07-01
DE19475021I2 (de) 2001-08-02
IL71545A0 (en) 1984-07-31
NL950002I2 (nl) 1998-04-01
AU2679684A (en) 1984-10-18
ZA842797B (en) 1985-11-27
SG39390G (en) 1990-11-23
ATE27696T1 (de) 1987-06-15
JPS59205341A (ja) 1984-11-20
AU574353B2 (en) 1988-07-07
CY1549A (en) 1991-03-22

Similar Documents

Publication Publication Date Title
AU574353B2 (en) Naphthoquinone derivatives
FI853622L (fi) Diarylacetylener, deras framstaellning och anvaendning.
FI860914A0 (fi) Fenylkarbamater.
FI851836A0 (fi) Foerfarande foer framstaellning av nya kompositioner.
DK104694A (da) Fremgangsmåde til fremstilling af 4-demethoxy-7-deoxy-daunomycinon eller 4-demethoxy-danomycinon
IT8622394V0 (it) Occhiali con lenti sostituibili.
NO924672L (no) Metode for fremstilling av interferon alfa-2-krystaller
DE3584393D1 (de) 1-heteroaryl-4-aryl-pyrozolin-5-one.
BG35328A3 (en) Method for preparing imidodisulphamidic derivatives
FI892675A0 (fi) 2,6-dihalogenpyridin-3 -karboxylsyraderivat och deras framstaellning.
SE8600017D0 (sv) New compound
SE8601824L (sv) Karbapenem-mellanprodukter
FI861118A0 (fi) Foereningar befraemjande radionukleiders maolspecificitet och anvaendning av dessa.
BG38338A3 (en) Method for preparing 6 alpha- methylhydrocortisonic derivatives
NO890531L (no) 3,4-dihydro-2-alkyl-3-okso-n-aryl-2h-(1)benzotieno(3,2-e)-1,2-tiazin-4-karboksamid-1,1-dioksyder.
ES8400384A1 (es) Procedimiento para la preparacion de derivados de carbaciclina.
AU566911B2 (en) Triazalo pyridoquinazolines and their use in the treatment of allergies
ES8506319A1 (es) Un nuevo procedimiento para la preparacion de cefalosporinas.
GB1361777A (en) 3-alkoxy-5-substituted phenylacetic acids
JPS539763A (en) Methylidene-amine derivatives
IT1131957B (it) Bloccaggio morbido per ceniere d'occhiale
ES8609321A1 (es) Un procedimiento para preparar un derivado de quinolizinona
IT8546845A0 (it) Gruppo bivalente per l'effettuazione di iniezioni nel cavo orale
BG35329A3 (en) Method for preparing n- phenyl- n- acetyl- 3- amino- oxazolidin- 2- ons
FR2128168A2 (en) Pyrazine carboxamido ethyl benzene sulphonyl ureas - - hypoglycemiants